Cargando…
TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer
Gastric cancer is one of the most common cancers worldwide and is the third leading cause of cancer-related deaths globally. Although significant progress has been made in the diagnosis and treatment for the cancer, less improvement has been made in overall survival rate. Thus, there is an urgent ne...
Autores principales: | Zhang, Beili, Wu, Jugang, Cai, Yantao, Luo, Meng, Wang, Bing, Gu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460344/ https://www.ncbi.nlm.nih.gov/pubmed/30811526 http://dx.doi.org/10.1093/abbs/gmz015 |
Ejemplares similares
-
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
por: Fan, Z, et al.
Publicado: (2017) -
The KEAP1–NRF2 System in Cancer
por: Taguchi, Keiko, et al.
Publicado: (2017) -
Keap1/Nrf2 Signaling Pathway
por: Sykiotis, Gerasimos P.
Publicado: (2021) -
Structural basis of Keap1 interactions with Nrf2
por: Canning, Peter, et al.
Publicado: (2015) -
Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals
por: Bhattacharjee, Shamee, et al.
Publicado: (2020)